SlideShare uma empresa Scribd logo
1 de 19
Baixar para ler offline
Definition ,[object Object],[object Object],[object Object],[object Object]
Causes of Nonsyncopal Attacks (Commonly Misdiagnosed as Syncope) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Causes of Syncope
Age-Dependent Causes of Syncope Mayo Clinic:  1996-1998 (n=1,291) <65 years n=607  65 years n=684 13% 43% 3% 17% 24% 30% 23% 10% 18% 19% Cardiogenic  Vasovagal  CHS  Undetermined  Other
SYNCOPE:  Natural History Kapoor:  Medicine, 1990 10 20 30 40 50 60 0 1 2 3 4 5 0 1 2 3 4 5 Y ear of follow-up % Cardiogenic Undetermined Noncardiac Mortality Sudden Death
Emergency Department Risk Stratification of Patients With Syncope of Unknown Cause   High-risk group  Intermediate-risk group  Low-risk group  Chest pain  Signs of chronic heart failure Moderate/severe valvular disease History of ventricular arrhythmias Electrocardiographic/cardiac monitor findings of ischemia Prolonged QTc (>500 ms) Trifascicular block or pauses between 2 and 3 s Persistent sinus bradycardia between 40 and 60 beats/min Atrial fibrillation and nonsustained ventricular tachycardia without symptoms Cardiac devices (pacemaker or defibrillator) with dysfunction  Age =50 y With history of CAD, MI, CHF without active symptoms or signs while taking cardiac medications Bundle-branch block or Q wave without acute changes Family history of premature (<50 y), unexplained sudden death Symptoms not consistent with a reflex-mediated or vasovagal cause  Cardiac devices without evidence of dysfunction  Physician’s judgment that suspicion of cardiac syncope is reasonable  Age <50 y With no history of   Cardiovascular disease   Symptoms consistent with reflex-mediated or vasovagal syncope Normal findings on cardiovascular examination Normal electrocardiographic findings
85-year-old patient with valvular heart disease and congestive heart failure.
Atrial tachycardia ,[object Object],[object Object],[object Object],[object Object],[object Object]
51-year-old female with palpitations.  Regular Rate 142 bpm No clear P waves before QRS – Not sinus rhythm Retrograde P-waves, with short RP interval
Mechanism of Reentry An impulse initiated in the SA node passes through both the AV node and the accessory pathway A premature atrial impulse occurs and reaches the accessory pathway when it is refractory, but conduction occurs through the AV node The impulse takes sufficient time to circulate through the AV node to allow the accessory pathway to recover initiating reentry
Mechanisms of Supraventricular Tachycardia AVNRT – the AV node is divided into two pathways and the activation of the atria and ventricle is synchronous so the retrograde P-wave is buried.  Account for 60% of SVT. Usu are 150-200 bpm Orthodromic AVRT –  mechanism seen on previous slide.  Usually, L atrium is the first site retrograde atrial activation. Accounts for 30% of SVT Widened   QRS Antidromic AVRT – activation occurs in the opposite direction resulting in wide complex tachycardia that is indistinguishable from V tach
Regular Rate 166 bpm   No clear P waves before QRS – Not sinus rhythm Wide QRS  160 ms RBBB pattern DDx of regular wide complex tachycardia ,[object Object],[object Object],[object Object],Retrograde P-waves associated with the QRS complex
Regular, Ventricular Rate 150 bpm Wide QRS complex 180 ms ,[object Object],[object Object],[object Object],DDx of regular wide complex tachycardia (WCT)
A question of aberrancy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1 2
The Thyroid and the Heart
Thyroid Hormone Actions on the Heart ,[object Object],[object Object],[object Object]
Hemodynamic Alterations in Thyroid Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hyperthyroidism ,[object Object],[object Object],[object Object],[object Object],[object Object]
Hypothyroidism ,[object Object],[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados (20)

Hypertension
HypertensionHypertension
Hypertension
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
 
Heart Failure
Heart FailureHeart Failure
Heart Failure
 
Approach to heart failure cases
Approach to heart failure casesApproach to heart failure cases
Approach to heart failure cases
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Heart failure
Heart failureHeart failure
Heart failure
 
Hypertension
HypertensionHypertension
Hypertension
 
Heart failure – an update [autosaved]
Heart failure – an update [autosaved]Heart failure – an update [autosaved]
Heart failure – an update [autosaved]
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
 
Heart failure ppt
Heart failure ppt Heart failure ppt
Heart failure ppt
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failure
 
Hypertension
HypertensionHypertension
Hypertension
 
Arterial Hypertension
Arterial HypertensionArterial Hypertension
Arterial Hypertension
 
cardiogenic shock
cardiogenic shock cardiogenic shock
cardiogenic shock
 
Essential Hypertension
Essential HypertensionEssential Hypertension
Essential Hypertension
 
Thyroid diseade and the Heart
Thyroid diseade and the HeartThyroid diseade and the Heart
Thyroid diseade and the Heart
 
Heart Failure with Reduced Ejection Fraction
Heart Failure with Reduced Ejection FractionHeart Failure with Reduced Ejection Fraction
Heart Failure with Reduced Ejection Fraction
 

Destaque

Thyroid disease and the Heart
Thyroid disease and the HeartThyroid disease and the Heart
Thyroid disease and the HeartABM Kamrul Hasan
 
Thyroid disease in Pregnancy
Thyroid disease in PregnancyThyroid disease in Pregnancy
Thyroid disease in Pregnancyhemnathsubedii
 
03. diseases of thyroid gland
03. diseases of thyroid gland03. diseases of thyroid gland
03. diseases of thyroid glandFahad Zakwan
 
Dental management in thyroid patient
Dental management in thyroid patient Dental management in thyroid patient
Dental management in thyroid patient Pakapat Wi
 

Destaque (6)

Thyroid disease and the Heart
Thyroid disease and the HeartThyroid disease and the Heart
Thyroid disease and the Heart
 
Thyroid disease in Pregnancy
Thyroid disease in PregnancyThyroid disease in Pregnancy
Thyroid disease in Pregnancy
 
Diseases of thyroid gland
Diseases of thyroid gland Diseases of thyroid gland
Diseases of thyroid gland
 
Basedow
BasedowBasedow
Basedow
 
03. diseases of thyroid gland
03. diseases of thyroid gland03. diseases of thyroid gland
03. diseases of thyroid gland
 
Dental management in thyroid patient
Dental management in thyroid patient Dental management in thyroid patient
Dental management in thyroid patient
 

Semelhante a Thyroid and the Heart

Arrhythmias general
Arrhythmias generalArrhythmias general
Arrhythmias generalAdarsh
 
ECG Monitoring (Basic of ECG)
ECG  Monitoring  (Basic of ECG)ECG  Monitoring  (Basic of ECG)
ECG Monitoring (Basic of ECG)Gajan Gaja
 
Supra ventri cular arrhythmia 2021
Supra ventri cular arrhythmia  2021Supra ventri cular arrhythmia  2021
Supra ventri cular arrhythmia 2021rajasthan govt
 
EKG Module
EKG ModuleEKG Module
EKG Modulecallroom
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardiaPraveen Nagula
 
Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Varsha Shah
 
Paediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.pptPaediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.pptSalam467227
 
ECG session 3 د مازن الشباني.pdf
ECG session 3 د مازن الشباني.pdfECG session 3 د مازن الشباني.pdf
ECG session 3 د مازن الشباني.pdfcww5y7w8j6
 
Syncope and the ECG
Syncope and the ECGSyncope and the ECG
Syncope and the ECGSCGH ED CME
 
Tachyarrhythmia Management
Tachyarrhythmia ManagementTachyarrhythmia Management
Tachyarrhythmia ManagementSCGH ED CME
 
cardiac rhythm disorders in newborns
cardiac rhythm disorders in newbornscardiac rhythm disorders in newborns
cardiac rhythm disorders in newbornsDr Praman Kushwah
 

Semelhante a Thyroid and the Heart (20)

Arrhythmias general
Arrhythmias generalArrhythmias general
Arrhythmias general
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 
Brady arryhthmias
Brady arryhthmiasBrady arryhthmias
Brady arryhthmias
 
ECG Monitoring (Basic of ECG)
ECG  Monitoring  (Basic of ECG)ECG  Monitoring  (Basic of ECG)
ECG Monitoring (Basic of ECG)
 
Supra ventri cular arrhythmia 2021
Supra ventri cular arrhythmia  2021Supra ventri cular arrhythmia  2021
Supra ventri cular arrhythmia 2021
 
EKG Module
EKG ModuleEKG Module
EKG Module
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Approach to svt
Approach to svt Approach to svt
Approach to svt
 
SVT final.pptx
SVT final.pptxSVT final.pptx
SVT final.pptx
 
Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]
 
Paediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.pptPaediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.ppt
 
Ecg for acls
Ecg for aclsEcg for acls
Ecg for acls
 
Arrhythmia
ArrhythmiaArrhythmia
Arrhythmia
 
ECG Rhythm abnormality for undergraduates
ECG Rhythm abnormality for undergraduatesECG Rhythm abnormality for undergraduates
ECG Rhythm abnormality for undergraduates
 
ECG session 3 د مازن الشباني.pdf
ECG session 3 د مازن الشباني.pdfECG session 3 د مازن الشباني.pdf
ECG session 3 د مازن الشباني.pdf
 
Syncope and the ECG
Syncope and the ECGSyncope and the ECG
Syncope and the ECG
 
Tachyarrhythmia Management
Tachyarrhythmia ManagementTachyarrhythmia Management
Tachyarrhythmia Management
 
Bradyarryhthmias
BradyarryhthmiasBradyarryhthmias
Bradyarryhthmias
 
cardiac rhythm disorders in newborns
cardiac rhythm disorders in newbornscardiac rhythm disorders in newborns
cardiac rhythm disorders in newborns
 
EP diagnosis of WIDE COMPLEX TACHYCARDIA
EP diagnosis of WIDE COMPLEX TACHYCARDIAEP diagnosis of WIDE COMPLEX TACHYCARDIA
EP diagnosis of WIDE COMPLEX TACHYCARDIA
 

Mais de callroom

Test Presentation
Test PresentationTest Presentation
Test Presentationcallroom
 
Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011callroom
 
Flail Leaflet
Flail LeafletFlail Leaflet
Flail Leafletcallroom
 
Fat versus Fit
Fat versus FitFat versus Fit
Fat versus Fitcallroom
 
Cardiac MR and viability
Cardiac MR and viabilityCardiac MR and viability
Cardiac MR and viabilitycallroom
 
Cardiac MR and viability
Cardiac MR and viabilityCardiac MR and viability
Cardiac MR and viabilitycallroom
 
LFT Review
LFT ReviewLFT Review
LFT Reviewcallroom
 
testing123
testing123testing123
testing123callroom
 
Hypertrophic Cardiomyopathy
Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathycallroom
 
C. diff presentation
C. diff presentationC. diff presentation
C. diff presentationcallroom
 
Hemostasis and Thrombosis
Hemostasis and ThrombosisHemostasis and Thrombosis
Hemostasis and Thrombosiscallroom
 

Mais de callroom (20)

ppt6
ppt6ppt6
ppt6
 
PPT5
PPT5PPT5
PPT5
 
PPT2
PPT2PPT2
PPT2
 
PPT1
PPT1PPT1
PPT1
 
Test Presentation
Test PresentationTest Presentation
Test Presentation
 
Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011
 
Flail Leaflet
Flail LeafletFlail Leaflet
Flail Leaflet
 
Fat versus Fit
Fat versus FitFat versus Fit
Fat versus Fit
 
Cardiac MR and viability
Cardiac MR and viabilityCardiac MR and viability
Cardiac MR and viability
 
Cardiac MR and viability
Cardiac MR and viabilityCardiac MR and viability
Cardiac MR and viability
 
LFT Review
LFT ReviewLFT Review
LFT Review
 
testing123
testing123testing123
testing123
 
Hypertrophic Cardiomyopathy
Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
 
C. diff presentation
C. diff presentationC. diff presentation
C. diff presentation
 
test
testtest
test
 
Hemostasis and Thrombosis
Hemostasis and ThrombosisHemostasis and Thrombosis
Hemostasis and Thrombosis
 
 
 
qwqsqw
qwqsqwqwqsqw
qwqsqw
 
asaswwww
asaswwwwasaswwww
asaswwww
 

Thyroid and the Heart

  • 1.
  • 2.
  • 4. Age-Dependent Causes of Syncope Mayo Clinic: 1996-1998 (n=1,291) <65 years n=607  65 years n=684 13% 43% 3% 17% 24% 30% 23% 10% 18% 19% Cardiogenic Vasovagal CHS Undetermined Other
  • 5. SYNCOPE: Natural History Kapoor: Medicine, 1990 10 20 30 40 50 60 0 1 2 3 4 5 0 1 2 3 4 5 Y ear of follow-up % Cardiogenic Undetermined Noncardiac Mortality Sudden Death
  • 6. Emergency Department Risk Stratification of Patients With Syncope of Unknown Cause High-risk group Intermediate-risk group Low-risk group Chest pain Signs of chronic heart failure Moderate/severe valvular disease History of ventricular arrhythmias Electrocardiographic/cardiac monitor findings of ischemia Prolonged QTc (>500 ms) Trifascicular block or pauses between 2 and 3 s Persistent sinus bradycardia between 40 and 60 beats/min Atrial fibrillation and nonsustained ventricular tachycardia without symptoms Cardiac devices (pacemaker or defibrillator) with dysfunction Age =50 y With history of CAD, MI, CHF without active symptoms or signs while taking cardiac medications Bundle-branch block or Q wave without acute changes Family history of premature (<50 y), unexplained sudden death Symptoms not consistent with a reflex-mediated or vasovagal cause Cardiac devices without evidence of dysfunction Physician’s judgment that suspicion of cardiac syncope is reasonable Age <50 y With no history of   Cardiovascular disease   Symptoms consistent with reflex-mediated or vasovagal syncope Normal findings on cardiovascular examination Normal electrocardiographic findings
  • 7. 85-year-old patient with valvular heart disease and congestive heart failure.
  • 8.
  • 9. 51-year-old female with palpitations. Regular Rate 142 bpm No clear P waves before QRS – Not sinus rhythm Retrograde P-waves, with short RP interval
  • 10. Mechanism of Reentry An impulse initiated in the SA node passes through both the AV node and the accessory pathway A premature atrial impulse occurs and reaches the accessory pathway when it is refractory, but conduction occurs through the AV node The impulse takes sufficient time to circulate through the AV node to allow the accessory pathway to recover initiating reentry
  • 11. Mechanisms of Supraventricular Tachycardia AVNRT – the AV node is divided into two pathways and the activation of the atria and ventricle is synchronous so the retrograde P-wave is buried. Account for 60% of SVT. Usu are 150-200 bpm Orthodromic AVRT – mechanism seen on previous slide. Usually, L atrium is the first site retrograde atrial activation. Accounts for 30% of SVT Widened QRS Antidromic AVRT – activation occurs in the opposite direction resulting in wide complex tachycardia that is indistinguishable from V tach
  • 12.
  • 13.
  • 14.
  • 15. The Thyroid and the Heart
  • 16.
  • 17.
  • 18.
  • 19.